We are live on ! Find out more
FURX

FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX

Delisted

FURX was delisted on the 1st of July, 2014.

85 hedge funds and large institutions have $258M invested in FURIEX PHARMACEUTICALS INC COM STK (DE) in 2013 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 29 increasing their positions, 32 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

37% more capital invested

Capital invested by funds: $188M → $258M (+$69.7M)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

9% less repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 32

10% less funds holding

Funds holding: 9485 (-9)

44% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 18

45% less call options, than puts

Call options by funds: $2.5M | Put options by funds: $4.55M

Holders
85
Holders Change
-9
Holders Change %
-9.57%
% of All Funds
2.76%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.13%
New
10
Increased
29
Reduced
32
Closed
18
Calls
$2.5M
Puts
$4.55M
Net Calls
-$2.05M
Net Calls Change
+$540K
Name Holding Trade Value Shares
Change
Change in
Stake
SIM
26
Spark Investment Management
New York
$1.24M -$223K -5,400 -16%
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$1.19M -$821K -19,834 -42%
SBH
28
Segall Bryant & Hamill
Illinois
$1.16M +$1.2K +29 +0.1%
California Public Employees Retirement System
29
California Public Employees Retirement System
California
$1.12M -$144K -3,474 -12%
TAM
30
Tocqueville Asset Management
New York
$1.08M -$41.4K -1,000 -4%
Arrowstreet Capital
31
Arrowstreet Capital
Massachusetts
$874K +$39.7K +959 +5%
EI
32
EAM Investors
California
$842K +$170K +4,119 +27%
Charles Schwab
33
Charles Schwab
California
$841K +$75.8K +1,832 +11%
BIM
34
BlackRock Investment Management
Delaware
$826K +$28.1K +678 +4%
Morgan Stanley
35
Morgan Stanley
New York
$800K -$564K -13,620 -43%
RFC
36
Russell Frank Company
Washington
$790K +$25.7K +622 +4%
State Board of Administration of Florida Retirement System
37
State Board of Administration of Florida Retirement System
Florida
$714K -$439K -10,612 -40%
SO
38
STRS Ohio
Ohio
$655K
Deutsche Bank
39
Deutsche Bank
Germany
$592K +$113K +2,742 +25%
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$527K +$16.7K +404 +3%
AQR Capital Management
41
AQR Capital Management
Connecticut
$498K +$4.14K +100 +0.9%
TA
42
Teachers Advisors
New York
$431K +$21.3K +515 +6%
T. Rowe Price Associates
43
T. Rowe Price Associates
Maryland
$427K -$86.9K -2,100 -18%
OC
44
Oppenheimer & Co
New York
$417K
RAM
45
Redmond Asset Management
Virginia
$417K +$393K +9,489 New
Goldman Sachs
46
Goldman Sachs
New York
$387K -$155K -3,751 -30%
Group One Trading
47
Group One Trading
Illinois
$372K +$264K +6,368 +305%
VOYA Investment Management
48
VOYA Investment Management
Georgia
$355K
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$346K -$2.77K -67 -0.8%
ProShare Advisors
50
ProShare Advisors
Maryland
$344K +$45.3K +1,095 +16%

FURX Hedge Fund Activity: Q3 2013 in Review

85 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) for Q3 2013, worth a combined $258M — up 37% from $188M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of FURX and 10 opened new positions — a net loss of 8 holders — while 32 trimmed existing stakes and 29 added.

The largest buyer was Eagle Asset Management, opening a new position worth an estimated $11.5M. The largest seller was Global Alpha Capital Management, cutting an estimated $1.83M.

  • 85 institutional investors held FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) as of Q3 2013, down from 94 in Q2 2013.
  • Funds reported $258M of FURIEX PHARMACEUTICALS INC COM STK (DE) stock for Q3 2013, up 37% quarter-over-quarter.
  • 10 funds opened new FURIEX PHARMACEUTICALS INC COM STK (DE) positions in Q3 2013 and 18 closed out, a net change of -8 holders.
  • The largest FURIEX PHARMACEUTICALS INC COM STK (DE) buyer in Q3 2013 was Eagle Asset Management, an estimated $11.5M added.
  • The largest FURIEX PHARMACEUTICALS INC COM STK (DE) seller in Q3 2013 was Global Alpha Capital Management, an estimated $1.83M sold.

Based on aggregated 13F filings for Q3 2013.